Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Search Product Recalls

Try:····

Filters

Category

All Categories Food Medication Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Time Period

All Time Last 30 Days Last 90 Days Last Year

State

Severity

All Severities Class I (High Risk)Class II (Moderate)Class III (Low)

Source

All Sources FDA CPSC USDA NHTSA

Status

Include terminated recalls

Clear all filters

Showing 961–980 of 3363 results

Sort:

Newest first Oldest first

Calcium Citrate Plus (Vitamin Shoppe) – Sub-Potent Vitamin D (2020)

Sample analysis revealed product is sub-potent for Vitamin D

FDAJun 29, 2020Nationwide• Vitamin Shoppe

Nystatin Oral Suspension (VistaPharm) – Impurity peak excess (2020)

Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

FDAJun 23, 2020Nationwide• VistaPharm, Inc.

Tecfidera 240mg Capsules (Biogen) – Manufacturing deviation (2020)

cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.

Class IIILow

FDAJun 23, 2020IN, KY, MS +1 more• Biogen MA Inc.

Nystatin Oral Suspension (VistaPharm) – Impurity Specification Failure (2020)

Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

FDAJun 23, 2020Nationwide• VistaPharm, Inc.

Famotidine Injection (HF Acquisition) – Temperature Abuse (2020)

TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

FDAJun 17, 2020CT, IN• HF Acquisition Co. LLC

Pro-Advance Infant Formula (Similac) – Mislabeled Bottles (2020)

Water filled bottles labeled as Similac Pro-Advance.

FDAJun 11, 2020CT, MD, NJ +2 more• Abbott Nutrition, Division of Abbott Laboratories

Nabumetone Tablets (American Health Packaging) – Incomplete Labeling (2020)

Labeling Not Elsewhere Classified: The statement Pharmacist: Dispense with the accompanying Medication Guide was not included on the carton label.

FDAJun 10, 2020Nationwide• American Health Packaging

Prednisolone Sodium Phosphate (Akorn) – Discoloration Issue (2020)

Discoloration: Out of Specification (OOS) result for APHA Color Test.

FDAJun 5, 2020Nationwide• Akorn, Inc.

Brimonidine Tartrate Ophthalmic (Somerset) – Label Leaching Risk (2020)

Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

FDAJun 4, 2020Nationwide• SOMERSET THERAPEUTICS LLC

Brimonidine Tartrate Ophthalmic (Somerset) – Label Leaching Risk (2020)

Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

FDAJun 4, 2020Nationwide• SOMERSET THERAPEUTICS LLC

Brimonidine Tartrate Ophthalmic (Somerset) – Label Leaching Risk (2020)

Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

FDAJun 4, 2020Nationwide• SOMERSET THERAPEUTICS LLC

Lamotrigine Tablets (AVKARE) – Foreign Substance (2020)

Presence of Foreign Substance consistent with granules from desiccant packs used during storage

FDAMay 28, 2020Nationwide• AVKARE Inc.

Duavee Tablets (Pfizer) – Dissolution Failure (2020)

Failed Dissolution Specifications

FDAMay 27, 2020Nationwide• Pfizer Inc.

Lamotrigine Tablets (Jubilant Cadista) – Foreign Substance Risk (2020)

Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

FDAMay 26, 2020TN• Jubilant Cadista Pharmaceuticals, Inc.

Olanzapine Tablets (Aurobindo) – Impurity Specs (2020)

Failed Impurities/ Degradation Specifications

FDAMay 26, 2020Nationwide• Aurobindo Pharma USA Inc.

Olanzapine Tablets (Aurobindo Pharma) – Failed Impurity Test (2020)

Failed Impurities/ Degradation Specifications

FDAMay 26, 2020Nationwide• Aurobindo Pharma USA Inc.

Clonidine Hydrochloride Tablets (Unichem) – Benzophenone Migration (2020)

Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.

FDAMay 26, 2020Nationwide• UNICHEM PHARMACEUTICALS USA INC

Zilretta Injection (Flexion) – Temperature Abuse (2020)

Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded

FDAMay 19, 2020Nationwide• Flexion Therapeutics, Inc.

Gabapentin Tablets (InvaGen) – Impurity Test Failure (2020)

Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.

FDAMay 14, 2020Nationwide• InvaGen Pharmaceuticals, Inc.

Ethacrynic Acid Tablets (West-Ward Columbus) – Impurity Specifications (2020)

Failed Impurities/Degradation Specifications: Out of Specification for impurity 6 and total degradants.

FDAMay 13, 2020Nationwide• West-Ward Columbus Inc

1...47 484950 51...169

Page 49 of 169Next